Ischemic stroke affects nearly 690,000 patients a year in the United States and is the leading cause of long-term disability and the third leading cause of death [1, 2]. Acute ischemic stroke occurs when a clot becomes lodged in a cerebral vessel, cutting off blood supply to areas of the brain. There are two treatment options for acute ischemic stroke: tissue plasminogen activator (beneficial within the first 4 hours of stroke onset), and mechanical removal (beneficial from 4 to 8 hours after stroke onset). The two FDA approved clot removal devices (MERCI and Penumbra) for ischemic stroke are capable of achieving revascularization rates between 48% and 80% [3, 4].
- Nanotechnology Institute
EmboLess Mechanical Clot Removal Device: Possibility for Improving the Outcomes of Ischemic Stroke Patients
- Views Icon Views
- Share Icon Share
- Search Site
Perosky, J, Biddle, A, DeGraaf, K, Hovan, W, Li, CM, & Nagesh, S. "EmboLess Mechanical Clot Removal Device: Possibility for Improving the Outcomes of Ischemic Stroke Patients." Proceedings of the ASME 2010 5th Frontiers in Biomedical Devices Conference. ASME 2010 5th Frontiers in Biomedical Devices Conference and Exhibition. Newport Beach, California, USA. September 20–21, 2010. pp. 39-40. ASME. https://doi.org/10.1115/BioMed2010-32072
Download citation file: